On May 10, 2011, long before the current deadly meningitis outbreak, an official in the FDA regional office in Denver sent an email to a colleague in Boston detailing allegations that a Massachusetts drug compounder was illegally shipping drugs to Colorado hospitals.
The information came from Colorado state inspectors who had then passed the concerns along to the U.S. Food and Drug Administration.
But there the information stopped.
related articles »
WASHINGTON — The Food and Drug Administration says it has uncovered potential safety problems at 30 specialty pharmacies that were ...
BOSTON — The Massachusetts pharmacy board’s director has been fired for ignoring a complaint that a company linked to a ...
WASHINGTON — Medicare is coming under scrutiny in the meningitis outbreak that has rekindled doubts about the safety of the ...
As of Oct. 13, 185 cases of rare fungal meningitis associated with 14 deaths have been reported in 12 states. ...
